Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Anheuser Busch Inbev SA NV (ADR) (BUD) A Good Stock To Buy?

Is Anheuser Busch Inbev SA NV (ADR) (NYSE:BUD) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy league graduates, expert network advisers, and supply chain tipsters working or consulting for them. There is not a shortage of news stories covering failed hedge fund investments (for some reason media paid a ton of attention to Ackman’s gigantic JC Penney and Valeant failures) and it is a fact that hedge funds’ picks don’t beat the market 100% of the time, but their consensus picks have historically done very well and have outperformed the market after adjusting for risk.

Smart money seems to be turning less optimistic about Anheuser Busch Inbev SA NV (ADR) (NYSE:BUD). At the end of September, 32 funds tracked by Insider Monkey held shares of the company, down from 35 funds at the end of June. At the end of this article we will also compare BUD to other stocks including Royal Dutch Shell plc (ADR) (NYSE:RDS), Chevron Corporation (NYSE:CVX), and Alibaba Group Holding Ltd (NYSE:BABA) to get a better sense of its popularity.

Follow Anheuser Busch Inbev Sa Nv (NYSE:BUD)
Trade (NYSE:BUD) Now!

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.

drink, alcoholic, brewed, brewing, barrel, pub, ale, white, wheat, tap, lager, cold, mug, bar, light, drink, hops, gold, woode

Valentyn Volkov/

Keeping this in mind, we’re going to take a look at the key action regarding Anheuser Busch Inbev SA NV (ADR) (NYSE:BUD).

How have hedgies been trading Anheuser Busch Inbev SA NV (ADR) (NYSE:BUD)?

A total of 32 of the hedge funds tracked by Insider Monkey were long Anheuser Busch Inbev SA NV (ADR) (NYSE:BUD) at the end of the third quarter, which represents a decline of 9% from the end of June. With the smart money’s sentiment swirling, there exists a select group of key hedge fund managers who were boosting their stakes substantially (or already accumulated large positions).


According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Soroban Capital Partners, managed by Eric W. Mandelblatt, holds the largest position in Anheuser Busch Inbev SA NV (ADR) (NYSE:BUD). Soroban Capital Partners has a $1.158 billion call position in the stock, comprising 7% of its 13F portfolio. The same fund also has a $1.0622 billion position held in shares. Other members of the smart money that hold long positions comprise Tom Russo’s Gardner Russo & Gardner, Ken Fisher’s Fisher Asset Management and Doug Silverman, and Alexander Klabin’s Senator Investment Group.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.